Simpson Thacher represented the underwriters, led by Goldman Sachs & Co. LLC, Evercore Group L.L.C., Morgan Stanley & Co. LLC and UBS Securities LLC, in connection with the public offering by Colfax Corporation (“Colfax”) of an aggregate of 16,100,000 shares of Colfax’s common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. The offering raised approximately $741 million in aggregate gross proceeds for Colfax and closed on March 19, 2021.
Colfax is a leading diversified technology company that provides specialty medical technologies and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands.
The Simpson Thacher team for this transaction included Roxane Reardon, Richard Fenyes and Hyo Min Kim (Capital Markets); Andrew Purcell and Suzy Yaster (Tax); Jeanne Annarumma (Executive Compensation and Employee Benefits); Jennie Getsin (FINRA & Blue Sky); Adeeb Fadil (Environmental); Vanessa Burrows (Healthcare); and Genevieve Dorment (IP).